The global autologous stem cell & non-stem cell therapies market, valued at US$3.9B in 2023, is forecasted to grow at a 32.3% CAGR, reaching US$5.5B by 2024 and US$22.2B by 2029. The major factor ...
The global organ-on-chip market, valued at US$89,202T in 2023, is forecasted to grow at a 38.6% CAGR, reaching US$123,285T by 2024 and US$631,073T by 2029. Growth in this market can mainly be att ...
The global GLP-1 analogues market, valued at US$37.4B in 2023, is forecasted to grow at a 33.2% CAGR, reaching US$47.4B by 2024 and US$471.1B by 2032. The comprehensive research encompasses an ex ...
The global CAR T-cell Therapy market, valued at US$37.4B in 2023, is forecasted to grow at a 39.6% CAGR, reaching US$5.5B by 2024 and US$29.0B by 2029. The growth of this market due to the rise i ...
The global oral proteins and peptides market, valued at US$7.35B in 2024, is forecasted to grow at a 22.1% CAGR, reaching US$8.85B by 2025 and US$24.00B by 2030.
The global artificial intelligence in precision medicine market, valued at US$0.60B in 2023, is forecasted to grow at a 30.7% CAGR, reaching US$0.78B by 2024 and US$3.92B by 2030. Growth in preci ...
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this m ...
The global immunotherapy drugs market, valued at US$255.9B in 2023, is forecasted to grow at a 15.3% CAGR, reaching US$285.3B by 2024 and US$580.6B by 2029. This growth is driven by technological ...
The global topical drug delivery market in terms of revenue was estimated to be worth USD 207.4 billion in 2022 and is poised to reach USD 317.8 billion by 2027, growing at a CAGR of 8.9% from 20 ...
The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024, at a CAGR of 6.5%. The prominent players operating in the healthcare distribution market are McKesson Corpora ...
The size of global antibody therapeutics market in terms of revenue was estimated to be worth USD 247.3 billion in 2023 and is poised to reach USD 479.0 billion by 2028, growing at a CAGR of 14.1 ...
The global monoclonal antibody therapeutics market, valued at US$222.6B in 2023, is forecasted to grow at a 14.5% CAGR, reaching US$252.6B by 2024 and US$497.5B by 2029. Driving factors of the ma ...
Latent demand for you, for your prospective client, or your prospective partners